Jul. 1 at 6:12 AM
$NAGE AI Overview In a major patent victory for chemical and specialty materials company W.R. Grace & Co., a Delaware federal judge rejected supplement maker Elysium Health's attempts to void a patent covering vitamin B3 supplements. This decision officially upholds a
$3.6 million willful infringement verdict handed down to Elysium over their "Basis" product.The Case at a GlanceThe Plaintiff: W.R. Grace & Co., which holds several patents related to the crystalline form of nicotinamide riboside (a form of vitamin B3) used in anti-aging and energy supplements.The Defendant: Elysium Health, makers of the dietary supplement "Basis".The Core Issue: Grace sued Elysium in August 2020, claiming the unauthorized use of their patented ingredients in the Basis formula.The Verdict: In August 2023, a jury found that Elysium directly and willfully infringed on two Grace patents (U.S. Patent Nos. 10,323,058 and 10,189,872), ordering over
$3.6 million in compensatory damages. continued
